You searched for "globe"
Study finds telemedicine improves care for children with eye cancer
Orbis announces new research that finds telemedicine can improve care for children with retinoblastoma, a form of childhood cancer that can lead to blindness. The study, published in JCO Global Oncology, is the first to show that virtual mentor-mentee relationships...Sustainability in eyecare: Intraocular gases and the climate emergency
In 2020 the NHS became the first national health system to commit to delivering ‘net zero’ carbon emissions by 2040. The author investigates how the impact of ophthalmic surgery can be reduced. Medical gases have been used in ophthalmic surgery...Canon Medical announces Sense Medical as new UK distributor
Canon Medical Systems Europe today announced that it has signed an agreement with Sense Medical to be the official exclusive distributor of their ophthalmic eye care products within the United Kingdom and Ireland.Heidelberg Engineering’s Tosh Vadhia announced as new ambassador for Orbis UK
Tosh Vadhia, Head of Global Accounts at Heidelberg Engineering joins blindness prevention charity Orbis to help raise awareness of avoidable sight loss. Through Tosh Vadhia’s support, Heidelberg Engineering has played a key role in supporting Orbis’s mission to end avoidable...The paradox of green: When environmental solutions lead to unintended harm
The global drive toward environmental sustainability is increasingly hampered not by outright denial, but by well-meaning solutions that conceal perverse incentives and unintended ecological consequences. Many popular ‘green’ measures, adopted by simplifying complex environmental challenges into easy substitutions or offsets,...New rules on capturing a homeless patient’s address will correct ‘major health inequality’, says the AOP
The Association of Optometrists (AOP) has welcomed an announcement by NHS England, which confirms that patients without a fixed address, including people who are homeless or rough sleeping, have a route to access NHS sight care by proving an alternative address.BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.
Management of diabetic macular oedema (DMO)
The authors present guidelines on current diagnostic and therapeutic procedures in the management of DMO. Fluorescein angiography (FA) and optical coherence tomography (OCT) are recommended before starting treatment to help diagnose and stage DMO, and can be repeated if there...
Effects of phacoemulsification on IOP and drug use in glaucoma
For patients with comorbid cataract and primary open-angle glaucoma (POAG), guidance is lacking as to whether cataract extraction and traditional filtering surgery should be performed as a staged or combined procedure. Achieving this guidance requires an evidence-based understanding of the...
Does intravitreal bevacizumab help in diabetic retinopathy related vitreous haemorrhage?
This retrospective, interventional case series, aimed to assess the effectiveness of intravitreal bevacizumab (IVB) in vitreous haemorrhage secondary to proliferative diabetic retinopathy. The primary outcome was the rate of vitrectomy (PPV) after IVB, with secondary outcomes the number of IVB...
Fingolimod: ocular adverse effects
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....
